ELife digest feature: DOI: http://dx.doi.org/10.7554/eLife.21697.002
This year the Parc de la Ciutadella in Barcelona will be hosting the eleventh edition of the Science Festival.
No ho sé - RAC1
In an interview on the programme “No ho sé”, presented by Joan Maria Pou on RAC1, Manuel Serrano, ICREA researcher at IRB Barcelona, has talked about regenerative medicine and the challenges that it faces before it can become a reality.
The newspaper “El País” devotes a feature to a recent study on metastatic breast cancer headed by Toni Celià-Terrassa, associate researcher at Princeton University, and includes the opinion of Roger Gomis, ICREA researcher and group leader of the Growth Control and Cancer Metastasis Lab at IRB Barcelona.
Pa ciència la nostra
The radio programme "Pa ciència, la nostra", presented by Daniel Arbós i Màrius Belles, has talked about the Open Day at IRB Barcelona, which was held on Saturday 13 May.
Felice Alessio Bava
former PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Quick facts about IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.